Home | Recruitment

Pending

Trials by recruitment status

Public Titlesort icon Date of registration Sponsor
Safety evaluation of Bacillus coagulans AO1167 for its use as a probiotic in humans 07/08/2023 HHA
Safety evaluation of Bacillus clausii AO1125 for its use as a probiotic in humans 07/08/2023 HHA
Safety and pharmacokinetics of CIGB-552 22/05/2015 CIGB
Safety and immunogenicity of VCN7-T in infants of 2 and 3 months. Phase I/II. 28/04/2017 FINLAY
Safety and immunogenicity of the CIGB 2020. 14/07/2020 CIGB
Safety and efficacy of VAXIRA® in advanced NSCLC patients not progressing after first line chemotherapy. Phase III. 01/10/2020 CIM
Safety and efficacy of CIMAvax®-EGF in combination with tyrosine kinase inhibitors in patients with advanced stage Non-Small Cell Lung Cancer and EGFR mutations 22/05/2021 CIM
Rectal ozone therapy in high-risk symptomatic SARS-CoV-2 positive patients 15/07/2021 CPN
Rectal Ozone in the COVID-19 treatment 05/06/2020 CPN
Racotumomab-alum for recurrent platimun-sensitive epithelial ovarian cancer 08/07/2015 CIM
Racotumomab-alum cancer vaccine for solid tumors in pediatric patients 15/12/2015 CIM
Racotumomab vaccine- Lung Cancer- Adults-predictors of response - Exploratory 09/07/2018 CIM
Quimi-Hib® and Quimi-Hib(AlPO4) vaccines in an accelerated 6-10-14 weeks primary vaccination series 2012-09-12 CIGB
Quality of Life and safety of the nutritional supplement Deprexil® or Placebo in combination with cognitive stimulation treatment in patients with Mild Cognitive Impairment and Mild Alzheimer's Dementia. 07/03/2024 CATALYSIS
Quality of life and safety of CARMINAL® nutritional supplement in patients with mild or moderate ulcerative colitis 29/02/2024 CATALYSIS
Preventive use of CIMAvax-EGF in patients at high risk of lung cancer. PREVAX 21/05/2021 CIM
Policosanol-Atorvastatina for Ictus 02/09/2013 CPN
Policosanol in patients with pre-hypertension or with grade I hypertension 30/06/2021 CPN
Policosanol in patients with metabolic syndrome and ischaemic cardiopaty 27/12/2016 CPN
Policosanol + aspirin in post-stroke cognitive impairment 30/06/2021 CPN